Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 10/20 | 0.41 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA4 | P22748 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA6 | P23280 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TPMT | P51580 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31075666 | 1.00 | ADRB2 (0.41) | ADRB2ABCB11CA2CA4CA1 | |
| SCHEMBL31076037 | 1.00 | ADRB2 (0.41) | ADRB2ABCB11CA2CA4CA1 | |
| SCHEMBL31075765 | 0.84 | CA2 (0.35) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL31076303 | 0.84 | CA2 (0.35) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL31063360 | 0.81 | CA2 (0.38) | ADRB2CA2CA4HSD17B10TPMT | |
| SCHEMBL9957836 | 0.81 | CA2 (0.41) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL31063174 | 0.81 | CA2 (0.41) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL31063457 | 0.78 | CA2 (0.38) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL31063371 | 0.78 | CA2 (0.41) | ADRB2CA2CA4CA1CA6 | |
| SCHEMBL25087486 | 0.74 | HTR2A (0.38) | ABCB11CA2CA4CA1CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4665458-A1 | INHIBITING ALPHA V BETA8 INTEGRIN | Morphic Therapeutic, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| WO-2024173572-A1 | INHIBITING α vβ8 INTEGRIN | MORPHIC THERAPEUTIC, INC. (US) | 2024-08-22 | — | — | WO | disclosed |